Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

Bosman A, Mendis KN.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):193-7. Review.

PMID:
18165492
[PubMed - indexed for MEDLINE]
Free Article
2.

Plasmodium malariae: parasite and disease.

Collins WE, Jeffery GM.

Clin Microbiol Rev. 2007 Oct;20(4):579-92. Review.

PMID:
17934075
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion.

Dinglasan RR, Alaganan A, Ghosh AK, Saito A, van Kuppevelt TH, Jacobs-Lorena M.

Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15882-7. Epub 2007 Sep 14.

PMID:
17873063
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen.

Dinglasan RR, Kalume DE, Kanzok SM, Ghosh AK, Muratova O, Pandey A, Jacobs-Lorena M.

Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13461-6. Epub 2007 Aug 2.

PMID:
17673553
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Transcriptional analysis of an immune-responsive serine protease from Indian malarial vector, Anopheles culicifacies.

Rodrigues J, Agrawal N, Sharma A, Malhotra P, Adak T, Chauhan VS, Bhatnagar RK.

BMC Mol Biol. 2007 May 15;8:33.

PMID:
17502004
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Crystal structure of aminopeptidase N (proteobacteria alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition.

Ito K, Nakajima Y, Onohara Y, Takeo M, Nakashima K, Matsubara F, Ito T, Yoshimoto T.

J Biol Chem. 2006 Nov 3;281(44):33664-76. Epub 2006 Aug 2.

PMID:
16885166
[PubMed - indexed for MEDLINE]
Free Article
7.

Using green fluorescent malaria parasites to screen for permissive vector mosquitoes.

Frischknecht F, Martin B, Thiery I, Bourgouin C, Menard R.

Malar J. 2006 Mar 28;5:23.

PMID:
16569221
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Two serine proteases from Anopheles dirus haemocytes exhibit changes in transcript abundance after infection of an incompatible rodent malaria parasite, Plasmodium yoelii.

Xu W, Huang FS, Hao HX, Duan JH, Qiu ZW.

Vet Parasitol. 2006 Jun 30;139(1-3):93-101. Epub 2006 Mar 29.

PMID:
16567047
[PubMed - indexed for MEDLINE]
9.

Plasmodium-mosquito interactions: a tale of dangerous liaisons.

Barillas-Mury C, Kumar S.

Cell Microbiol. 2005 Nov;7(11):1539-45. Review.

PMID:
16207241
[PubMed - indexed for MEDLINE]
10.

Progress in the development of aminopeptidase N (APN/CD13) inhibitors.

Xu W, Li Q.

Curr Med Chem Anticancer Agents. 2005 May;5(3):281-301. Review.

PMID:
15992355
[PubMed - indexed for MEDLINE]
11.

Malaria.

Greenwood BM, Bojang K, Whitty CJ, Targett GA.

Lancet. 2005 Apr 23-29;365(9469):1487-98. Review.

PMID:
15850634
[PubMed - indexed for MEDLINE]
12.

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A.

Vaccine. 2005 May 2;23(24):3131-8.

PMID:
15837212
[PubMed - indexed for MEDLINE]
13.

The global distribution of clinical episodes of Plasmodium falciparum malaria.

Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI.

Nature. 2005 Mar 10;434(7030):214-7.

PMID:
15759000
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Sugar epitopes as potential universal disease transmission blocking targets.

Dinglasan RR, Valenzuela JG, Azad AF.

Insect Biochem Mol Biol. 2005 Jan;35(1):1-10.

PMID:
15607650
[PubMed - indexed for MEDLINE]
15.

A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation.

Klemba M, Gluzman I, Goldberg DE.

J Biol Chem. 2004 Oct 8;279(41):43000-7. Epub 2004 Aug 10.

PMID:
15304495
[PubMed - indexed for MEDLINE]
Free Article
16.

Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.

Sattabongkot J, Tsuboi T, Hisaeda H, Tachibana M, Suwanabun N, Rungruang T, Cao YM, Stowers AW, Sirichaisinthop J, Coleman RE, Torii M.

Am J Trop Med Hyg. 2003 Nov;69(5):536-41.

PMID:
14695092
[PubMed - indexed for MEDLINE]
Free Article
17.

Monoclonal antibody MG96 completely blocks Plasmodium yoelii development in Anopheles stephensi.

Dinglasan RR, Fields I, Shahabuddin M, Azad AF, Sacci JB Jr.

Infect Immun. 2003 Dec;71(12):6995-7001.

PMID:
14638789
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Hisaeda H, Stowers AW, Tsuboi T, Collins WE, Sattabongkot JS, Suwanabun N, Torii M, Kaslow DC.

Infect Immun. 2000 Dec;68(12):6618-23.

PMID:
11083773
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes.

Han YS, Thompson J, Kafatos FC, Barillas-Mury C.

EMBO J. 2000 Nov 15;19(22):6030-40. Erratum in: EMBO J 2001 Mar 15;20(6):1483.

PMID:
11080150
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The journey of the malaria parasite in the mosquito: hopes for the new century.

Ghosh A, Edwards MJ, Jacobs-Lorena M.

Parasitol Today. 2000 May;16(5):196-201. Review.

PMID:
10782078
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk